Ariane Sickinghe

After working as a clinician for over a year in the field of Gynaecology & Obstetrics, I joined the Kok group in May 2025 as a PhD-student. My projects focus on finding clinical and translational biomarkers that predict the response to immunotherapy in Her2 negative breast cancer patients.

Hereby, I hope to contribute to developing personalized treatment regimens for high-risk breast cancer patients.